Ozempic and Wegovy officially moved off FDA’s drug shortage list
Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes and obesity, have officially been removed ...
Yearslong shortage of popular weight-loss and diabetes drugs is resolved, FDA says
In December, the FDA declared that shortages of treatments Zepbound and Mounjaro from another drugmaker, Eli Lilly and Co., ...
Why Hims & Hers Health Stock Is Plummeting Today
Hims & Hers, one of the most popular telehealth services in the world, is in danger of losing one of its central revenue sources. The U.S. Food and Drug Administration (FDA) removed semaglutide ...
US health agencies postpone rare diseases event in an unusual move
A two-day meeting aimed at raising awareness among policymakers and public about rare diseases scheduled for the end of the ...
The Dominion Post47m
House food dye ban bill advances, heads for passage; two preservatives added
The House of Delegates will take up a bill to ban a handful of synthetic dyes from foods sold in West Virginia starting ...